Literature DB >> 20304038

EV71: an emerging infectious disease vaccine target in the Far East?

Juan Xu1, Yuan Qian, Shixia Wang, Jill M Grimes Serrano, Wei Li, Zuhu Huang, Shan Lu.   

Abstract

Hand, foot, and mouth disease (HFMD) is a common viral illness in infants and children caused by viruses that belong to the enterovirus genus of the picornavirus family. Although most HFMD do not result in serious complications, outbreaks of HFMD caused by enterovirus 71 (EV71) can present with a high rate of neurological complications, including meningoencephalitis, pulmonary complications, and possibly death. HFMD caused by EV71 has become a major emerging infectious disease in Asia and the highly pathogenic potential of EV71 clearly requires the attention of world medical community. Although vaccine development for EV71 is active and ongoing in Asian countries, a greater joint effort is needed for vaccine researchers and developers in both developed and developing countries to produce a safe and effective EV71 vaccine. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304038     DOI: 10.1016/j.vaccine.2010.03.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.

Authors:  Bruce Y Lee; Angela R Wateska; Rachel R Bailey; Julie H Y Tai; Kristina M Bacon; Kenneth J Smith
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

Review 2.  Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.

Authors:  S Aswathyraj; G Arunkumar; E K Alidjinou; D Hober
Journal:  Med Microbiol Immunol       Date:  2016-07-12       Impact factor: 3.402

3.  Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2.

Authors:  Pan Chen; Zilin Song; Yonghe Qi; Xiaofeng Feng; Naiqing Xu; Yinyan Sun; Xing Wu; Xin Yao; Qunyin Mao; Xiuling Li; Wenjuan Dong; Xiaobo Wan; Niu Huang; Xinliang Shen; Zhenglun Liang; Wenhui Li
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

4.  Enterovirus 71 infection of monocytes with antibody-dependent enhancement.

Authors:  Shih-Min Wang; I-Chun Chen; Ling-Yao Su; Kao-Jean Huang; Huan-Yao Lei; Ching-Chuan Liu
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

5.  Modification of the untranslated regions of human enterovirus 71 impairs growth in a cell-specific manner.

Authors:  Chee Choy Kok; Patchara Phuektes; Emily Bek; Peter C McMinn
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

6.  Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation.

Authors:  Yuemei Hu; Gang Zeng; Kai Chu; Jing Zhang; Weixiao Han; Ying Zhang; Jing Li; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2018-04-11       Impact factor: 3.452

Review 7.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

8.  Producing infectious enterovirus type 71 in a rapid strategy.

Authors:  Jian-Feng Han; Rui-Yuan Cao; Xue Tian; Man Yu; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2010-06-04       Impact factor: 4.099

9.  GATA1/SP1 and miR-874 mediate enterovirus-71-induced apoptosis in a granzyme-B-dependent manner in Jurkat cells.

Authors:  Meijuan Zhang; Ying Chen; Xiangjun Cheng; Zhenzhen Cai; Shengfeng Qiu
Journal:  Arch Virol       Date:  2020-08-26       Impact factor: 2.574

Review 10.  [Neurological complications of infections with (novel) enteroviruses].

Authors:  N Möhn; T Skripuletz; M Stangel
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.